Context Optimal management of prostate cancer (PCa) patients with lymph node invasion at
radical prostatectomy and pelvic lymph node dissection still remains unclear. Objective To …

Background Conventional imaging using CT and bone scan has insufficient sensitivity when
staging men with high-risk localised prostate cancer. We aimed to investigate whether novel …

Purpose: The summary presented herein represents Part I of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment …

In patients with prostate cancer who have a high risk of pelvic nodal disease, the use of
elective whole pelvis radiotherapy is still controversial. Two large, randomised, controlled …

Background Innovations in treatments, imaging, and molecular characterisation in advanced
prostate cancer have improved outcomes, but there are still many aspects of management …

Background Innovations in imaging and molecular characterisation and the evolution of new
therapies have improved outcomes in advanced prostate cancer. Nonetheless, we continue …

Purpose: The summary presented herein represents Part II of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing principles of …

Background Long-term outcomes of patients treated with salvage lymph node dissection
(sLND) for nodal recurrence of prostate cancer (PCa) remain unknown. Objective To …

Purpose: The majority of men who undergo pelvic lymph node dissection at radical
prostatectomy have benign lymph node histology. The aim of this study was to assess the …

One of the challenges for the surgical management of prostate cancer is the lymphatic
spread of metastases. Lymph node metastases vary in size (micrometastases (< 2 mm) or …